AmplifyBio offers comprehensive, GMP-compliant supply chain and procurement services, including purchasing, scheduling, receiving, inventory management, QC testing, QA release, material kitting, and end-to-end sample tracking. Utilizing advanced ERP and LIMS systems, we ensure efficient, traceable processes and optimal laboratory workflows. Our inventory management and material kitting solutions streamline production, while our quality assurance protocols guarantee compliance at every stage.
With strategic logistics partnerships, robust risk mitigation strategies, and state-of-the-art storage solutions, including real-time environmental monitoring, AmplifyBio provides reliable and efficient support for global clinical import/export needs.
AmplifyBio provides efficient, GMP-compliant, and centralized services including purchasing, scheduling, receiving, inventory management, QC raw material testing, QA release, material kitting, and end-to-end sample tracking. Leverage our purchasing power for the best pricing from reliable suppliers, ensuring a steady supply of high-quality materials and services. Our expertise extends to facilitating the seamless movement of biologics across borders, guaranteeing compliance and quality assurance throughout the logistics process. Additionally, we provide tailored secondary packing and labeling services to meet specific needs, offering comprehensive support for all your supply chain and logistics requirements.
Advanced therapies experience 400% more chemistry, manufacturing, and control (CMC) related developmental disruptions when compared to other large molecule biologics such as mAbs. AmplifyBio is addressing that challenge by building manufacturing centers where robust characterization is integrated into a manufacturing strategy, ensuring that not only is process development critical but that also, the PRODUCT is the PRODUCT.
What do we mean by that? Process and analytic development is critical when manufacturing cell and gene therapies, but at AmplifyBio you will also identify the product characteristics that ensure the product at discovery, is the same one being scaled up.
Comprehensive service programs for the development of Cell and Gene Therapy (CGT), mRNA, and other advanced therapies from concept to commercial. Offering expertise and support in discovery, characterization, preclinical CRO safety testing, and scalable manufacturing available in an integrated, innovation-rich environment that goes beyond the value proposition offered by traditional CDMO and PDMO contract models.
